WO1996021448A1 - Resin particle, medical material and pharmaceutical preparation containing said resin particle - Google Patents
Resin particle, medical material and pharmaceutical preparation containing said resin particle Download PDFInfo
- Publication number
- WO1996021448A1 WO1996021448A1 PCT/JP1996/000004 JP9600004W WO9621448A1 WO 1996021448 A1 WO1996021448 A1 WO 1996021448A1 JP 9600004 W JP9600004 W JP 9600004W WO 9621448 A1 WO9621448 A1 WO 9621448A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cilostazol
- resin particle
- vinyl alcohol
- alcohol copolymer
- ethylene vinyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96900177A EP0794778A1 (en) | 1995-01-10 | 1996-01-04 | Resin particle, medical material and pharmaceutical preparation containing said resin particle |
AU43570/96A AU4357096A (en) | 1995-01-10 | 1996-01-04 | Resin particle, medical material and pharmaceutical preparation containing said resin particle |
MXPA/A/1997/005185A MXPA97005185A (en) | 1995-01-10 | 1997-07-09 | Particle of resin, medical material and pharmaceutical preparation containing such particle of res |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP228795 | 1995-01-10 | ||
JP7/2287 | 1995-01-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1996021448A1 true WO1996021448A1 (en) | 1996-07-18 |
Family
ID=11525167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1996/000004 WO1996021448A1 (en) | 1995-01-10 | 1996-01-04 | Resin particle, medical material and pharmaceutical preparation containing said resin particle |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0794778A1 (en) |
KR (1) | KR19980701292A (en) |
CN (1) | CN1168102A (en) |
AU (1) | AU4357096A (en) |
CA (1) | CA2208571A1 (en) |
WO (1) | WO1996021448A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000057881A1 (en) * | 1999-03-25 | 2000-10-05 | Otsuka Pharmaceutical Co., Ltd. | Cilostazol preparation |
WO2002102414A1 (en) * | 2001-06-14 | 2002-12-27 | Otsuka Pharmaceutical Co., Ltd. | Medicinal compositions |
WO2006030301A1 (en) * | 2004-09-17 | 2006-03-23 | Ranbaxy Laboratories Limited | Cilostazol- containing pharmaceutical composition based on particles of less than 50 micrometers |
WO2008100106A1 (en) * | 2007-02-16 | 2008-08-21 | Amorepacific Corporation | Controlled release preparation containing cilostazoland process for the preparation thereof |
AU2006343445B2 (en) * | 1998-11-02 | 2011-05-26 | Elan Pharma International Limited | Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor |
WO2014123244A1 (en) * | 2013-02-06 | 2014-08-14 | Otsuka Pharmaceutical Co., Ltd. | Solid dispersion comprising amorphous cilostazol |
US8821936B2 (en) | 2004-05-20 | 2014-09-02 | Otsuka Pharmaceutical Co., Ltd. | Solid pharmaceutical formulation |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20080076382A (en) * | 2007-02-15 | 2008-08-20 | (주)아모레퍼시픽 | Controlled-release preparation containing cilostazol and process for the preparation thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH683673A5 (en) * | 1991-10-01 | 1994-04-29 | Otsuka Pharma Co Ltd | Antithrombotic resin antithrombotic tubes, antithrombotic film and antithrombotic coating. |
WO1994014444A1 (en) * | 1992-12-24 | 1994-07-07 | Otsuka Pharmaceutical Co., Ltd. | Psoriasis remedy |
-
1996
- 1996-01-04 CN CN96191408A patent/CN1168102A/en active Pending
- 1996-01-04 CA CA002208571A patent/CA2208571A1/en not_active Abandoned
- 1996-01-04 WO PCT/JP1996/000004 patent/WO1996021448A1/en not_active Application Discontinuation
- 1996-01-04 AU AU43570/96A patent/AU4357096A/en not_active Abandoned
- 1996-01-04 EP EP96900177A patent/EP0794778A1/en not_active Withdrawn
-
1998
- 1998-05-15 KR KR1019970704681A patent/KR19980701292A/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH683673A5 (en) * | 1991-10-01 | 1994-04-29 | Otsuka Pharma Co Ltd | Antithrombotic resin antithrombotic tubes, antithrombotic film and antithrombotic coating. |
WO1994014444A1 (en) * | 1992-12-24 | 1994-07-07 | Otsuka Pharmaceutical Co., Ltd. | Psoriasis remedy |
Non-Patent Citations (1)
Title |
---|
CHEMICAL ABSTRACTS, Columbus, Ohio, US; * |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006343445B8 (en) * | 1998-11-02 | 2011-06-16 | Elan Pharma International Limited | Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor |
AU2006343445A8 (en) * | 1998-11-02 | 2011-06-16 | Elan Pharma International Limited | Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor |
AU2006343445B2 (en) * | 1998-11-02 | 2011-05-26 | Elan Pharma International Limited | Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor |
US7144585B1 (en) | 1999-03-25 | 2006-12-05 | Otsuka Pharmaceutical Co., Ltd. | Cilostazol preparation |
AU781881B2 (en) * | 1999-03-25 | 2005-06-16 | Otsuka Pharmaceutical Co., Ltd. | Cilostazol preparation |
WO2000057881A1 (en) * | 1999-03-25 | 2000-10-05 | Otsuka Pharmaceutical Co., Ltd. | Cilostazol preparation |
US7008920B2 (en) | 2001-06-14 | 2006-03-07 | Otsuka Pharmaceutical Co., Ltd. | Medicinal composition |
CN100350977C (en) * | 2001-06-14 | 2007-11-28 | 大塚制药株式会社 | Medicinal compositions |
US7531499B2 (en) | 2001-06-14 | 2009-05-12 | Otsuka Pharmaceutical Co., Ltd. | Medicinal composition |
US6884768B2 (en) | 2001-06-14 | 2005-04-26 | Otsuka Pharmaceutical Co., Ltd. | Medicinal compositions |
WO2002102414A1 (en) * | 2001-06-14 | 2002-12-27 | Otsuka Pharmaceutical Co., Ltd. | Medicinal compositions |
US8821936B2 (en) | 2004-05-20 | 2014-09-02 | Otsuka Pharmaceutical Co., Ltd. | Solid pharmaceutical formulation |
WO2006030301A1 (en) * | 2004-09-17 | 2006-03-23 | Ranbaxy Laboratories Limited | Cilostazol- containing pharmaceutical composition based on particles of less than 50 micrometers |
WO2008100106A1 (en) * | 2007-02-16 | 2008-08-21 | Amorepacific Corporation | Controlled release preparation containing cilostazoland process for the preparation thereof |
WO2014123244A1 (en) * | 2013-02-06 | 2014-08-14 | Otsuka Pharmaceutical Co., Ltd. | Solid dispersion comprising amorphous cilostazol |
US9555026B2 (en) | 2013-02-06 | 2017-01-31 | Otsuka Pharmaceutical Co., Ltd. | Solid dispersion comprising amorphous cilostazol |
AU2014215920B2 (en) * | 2013-02-06 | 2018-03-15 | Otsuka Pharmaceutical Co., Ltd. | Solid dispersion comprising amorphous cilostazol |
Also Published As
Publication number | Publication date |
---|---|
KR19980701292A (en) | 1998-05-15 |
EP0794778A1 (en) | 1997-09-17 |
CA2208571A1 (en) | 1996-07-18 |
AU4357096A (en) | 1996-07-31 |
CN1168102A (en) | 1997-12-17 |
MX9705185A (en) | 1997-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2124821C (en) | Novel solid pharmaceutical dispersions | |
EP0988863B1 (en) | Stable complexes of poorly soluble compounds | |
US4404183A (en) | Sustained release pharmaceutical composition of solid medical material | |
US3773920A (en) | Sustained release medicinal composition | |
EP0381219B1 (en) | Modified release gemfibrozil composition | |
JPH0122245B2 (en) | ||
DE69935609T2 (en) | FORMULATIONS CONTAINING CEFUROXIM-AXETIL | |
AU659114B2 (en) | Method for the manufacture of a controlled release solid unit dosage form | |
KR920006908B1 (en) | Process for preparing solid medicament preparation containing dihydropyridines | |
EP0794778A1 (en) | Resin particle, medical material and pharmaceutical preparation containing said resin particle | |
JP2004131393A (en) | Readily eluting pharmaceutical preparation | |
JPH0813736B2 (en) | Method for preparing tablets or dragee compositions containing heat-, light-, and moisture-sensitive active ingredients having a monoclinic crystal structure | |
DE69910188T2 (en) | MEDICINE CONTAINING CARVEDILOL | |
JPH04230209A (en) | Sustained release pharmaceutical preparation and method of its preparation | |
CA2878689A1 (en) | Crystalline forms of an hcv inhibitor | |
JPH08245389A (en) | Granular resin material, medical material and medicinal preparation containing same resin material | |
JPH029007B2 (en) | ||
JPH031288B2 (en) | ||
JPS62228017A (en) | Manufacture of solid quick release drug composition containing dihydropyridine | |
EP0209121B1 (en) | Sustained-release pharmaceutical composition and process for its preparation | |
CA2280925A1 (en) | Stabilized cefuroxime axetil | |
MXPA97005185A (en) | Particle of resin, medical material and pharmaceutical preparation containing such particle of res | |
CH670201A5 (en) | Solid dispersions of water-insol. drugs - comprising coherent crystals of drug in water-soluble matrix | |
WO2002083101A1 (en) | Controlled-release nimodipine tablet and method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 96191408.4 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA CN KR MX US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2208571 Country of ref document: CA Ref document number: 2208571 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996900177 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019970704681 Country of ref document: KR Ref document number: PA/a/1997/005185 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref document number: 1997 875525 Country of ref document: US Date of ref document: 19970710 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 1996900177 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996900177 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1019970704681 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1019970704681 Country of ref document: KR |